Skip to main content
Jin Li, MD, Neurology, Hawthorne, NY

Jin Li MD

Neuromuscular Medicine


Associate Professor, Neurology, New York Med Coll

Request Appointment
  • 19 Bradhurst AveSuite 3850SHawthorne, NY 10532

  • Book by Phone+1(914) 380-7246

  • Fax+1 914-493-2505

Overview of  Dr. Li

Dr. Jin Li is a neurologist in Hawthorne, NY and is affiliated with Westchester Medical Center. She received her medical degree from Beijing Medical University and has been in practice 24 years. She specializes in neuromuscular medicine and headache medicine.

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterResidency, Neurology, 1999 - 2002
  • Westchester Medical Center
    Westchester Medical CenterInternship, Internal Medicine, 1998 - 1999
  • Beijing Medical University
    Beijing Medical UniversityClass of 1993

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2027
  • OH State Medical License
    OH State Medical License Active through 2014
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Neuromuscular Medicine
    American Board of Psychiatry and Neurology Neuromuscular Medicine

Publications & Presentations

PubMed

Press Mentions

  • Nimotuzumab May Improve Overall Survival in Patients with KRAS Wild-Type Advanced Pancreatic Cancer
    Nimotuzumab May Improve Overall Survival in Patients with KRAS Wild-Type Advanced Pancreatic CancerJune 3rd, 2022
  • Yingli Pharma Announces Presentations on the Phase 1 Trials of Linperlisib, a PI3Kδ Selective Inhibitor, and YL-13027, an Oral TGFβR1 Inhibitor, at the American Society for Clinical Oncology 2021 Annual Meeting
    Yingli Pharma Announces Presentations on the Phase 1 Trials of Linperlisib, a PI3Kδ Selective Inhibitor, and YL-13027, an Oral TGFβR1 Inhibitor, at the American Society for Clinical Oncology 2021 Annual MeetingJune 4th, 2021
  • Henlius Plans to File the NDA of Novel Anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial Has Met the Primary Endpoint
    Henlius Plans to File the NDA of Novel Anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial Has Met the Primary EndpointMarch 29th, 2021
  • Join now to see all

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access Choice PPO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    Anthem Blue Preferred Plus POS
    Anthem Blue Preferred Select
    BCBS Blue Card PPO
    BCBS Georgia Blue Choice HMO
    BCBS Georgia BlueChoice Option POS
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HealthLink PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare HMO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: